| Year |
Citation |
Score |
| 2020 |
Linssen RSN, Ma J, Bem RA, Rubin BK. Rational use of mucoactive medications to treat pediatric airway disease. Paediatric Respiratory Reviews. PMID 32653467 DOI: 10.1016/J.Prrv.2020.06.007 |
0.377 |
|
| 2020 |
Chai G, Hassan A, Meng T, Lou L, Ma J, Simmers R, Zhou L, Rubin BK, Zhou QT, Longest PW, Hindle M, Xu Q. Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 102262. PMID 32623017 DOI: 10.1016/J.Nano.2020.102262 |
0.336 |
|
| 2018 |
Rubin BK. Unmet needs in cystic fibrosis. Expert Opinion On Biological Therapy. 18: 49-52. PMID 30063865 DOI: 10.1080/14712598.2018.1484101 |
0.356 |
|
| 2018 |
Kummarapurugu AB, Afosah DK, Sankaranarayanan NV, Gangji RN, Zheng S, Kennedy TP, Rubin BK, Voynow JA, Desai UR. Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis. The Journal of Biological Chemistry. PMID 29903912 DOI: 10.1074/Jbc.Ra118.002644 |
0.312 |
|
| 2018 |
Williams DM, Rubin BK. Clinical Pharmacology of Bronchodilator Medications. Respiratory Care. 63: 641-654. PMID 29794201 DOI: 10.4187/Respcare.06051 |
0.361 |
|
| 2017 |
Rubin BK, Zhao W, Winders TA. What do patients want from their asthma care doctors? Paediatric Respiratory Reviews. PMID 29395963 DOI: 10.1016/J.Prrv.2017.11.002 |
0.327 |
|
| 2017 |
Rubin BK. Cystic Fibrosis 2017-The Year in Review. Respiratory Care. PMID 29279361 DOI: 10.4187/Respcare.06052 |
0.318 |
|
| 2017 |
Ma J, Rubin BK, Voynow JA. Mucins, Mucus and Goblet Cells. Chest. PMID 29170036 DOI: 10.1016/J.Chest.2017.11.008 |
0.35 |
|
| 2017 |
Rubin BK. Draining the Swamp. Respiratory Care. 62: 639-640. PMID 28442591 DOI: 10.4187/Respcare.05511 |
0.359 |
|
| 2017 |
Komiya K, Ohta S, Arima K, Ogawa M, Suzuki S, Mitamura Y, Nunomura S, Nanri Y, Yoshihara T, Kawaguchi A, Kadota JI, Rubin BK, Izuhara K. Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. Respiratory Research. 18: 37. PMID 28219384 DOI: 10.1186/S12931-017-0519-8 |
0.375 |
|
| 2016 |
Suzaki I, Kawano S, Komiya K, Tanabe T, Akaba T, Asano K, Suzaki H, Izuhara K, Rubin BK. Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC. Respirology (Carlton, Vic.). PMID 27553766 DOI: 10.1111/Resp.12873 |
0.306 |
|
| 2016 |
Franchini ML, Athanazio R, Amato-Lourenço LF, Carreirão-Neto W, Saldiva PH, Lorenzi-Filho G, Rubin BK, Nakagawa NK. Oxygen with cold bubble humidification is no better than dry oxygen in preventing mucus dehydration, decreased mucociliary clearance, and decline in pulmonary function. Chest. PMID 27048871 DOI: 10.1016/J.Chest.2016.03.035 |
0.323 |
|
| 2015 |
Chillappagari S, Müller C, Mahavadi P, Guenther A, Nährlich L, Rosenblum J, Rubin BK, Henke MO. A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 26526358 DOI: 10.1016/J.Jcf.2015.10.008 |
0.322 |
|
| 2015 |
Bennett WD, Kala A, Duckworth H, Zeman KL, Wu J, Henderson A, Yopp M, Rubin BK. Effect of a single 1200 Mg dose of Mucinex(®) on mucociliary and cough clearance during an acute respiratory tract infection. Respiratory Medicine. PMID 26462765 DOI: 10.1016/J.Rmed.2015.09.017 |
0.311 |
|
| 2015 |
Tanabe T, Rubin BK. Airway goblet cells secrete pro-inflammatory cytokines, chemokines and growth factors. Chest. PMID 26402158 DOI: 10.1378/Chest.15-0947 |
0.301 |
|
| 2015 |
Chillappagari S, Preuss J, Licht S, Müller C, Mahavadi P, Sarode G, Vogelmeier C, Guenther A, Nahrlich L, Rubin BK, Henke MO. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction. Respiratory Research. 16: 85. PMID 26169056 DOI: 10.1186/S12931-015-0247-X |
0.351 |
|
| 2015 |
Rubin BK. Aerosol Medications for Treatment of Mucus Clearance Disorders. Respiratory Care. 60: 825-32. PMID 26070577 DOI: 10.4187/Respcare.04087 |
0.341 |
|
| 2015 |
Hara Y, Shinkai M, Kanoh S, Kawana A, Rubin BK, Matsubara O, Kaneko T. Clinico-pathological analysis referring hemeoxygenase-1 in acute fibrinous and organizing pneumonia patients. Respiratory Medicine Case Reports. 14: 53-6. PMID 26029580 DOI: 10.1016/J.Rmcr.2015.01.003 |
0.303 |
|
| 2015 |
Rubin BK. Asthma myths, controversies, and dogma. Paediatric Respiratory Reviews. 16: 83-7. PMID 25245191 DOI: 10.1016/J.Prrv.2014.09.001 |
0.312 |
|
| 2015 |
Hara Y, Shinkai M, Rubin BK. Biomarkers for Staging and Evaluating the Therapy for Idiopathic Pulmonary Fibrosis Clinical Pulmonary Medicine. 22: 165-171. DOI: 10.1097/Cpm.0000000000000111 |
0.351 |
|
| 2014 |
Brant TC, Yoshida CT, Carvalho Tde S, Nicola ML, Martins JA, Braga LM, Oliveira RC, Leyton V, André CS, Saldiva PH, Rubin BK, Nakagawa NK. Mucociliary clearance, airway inflammation and nasal symptoms in urban motorcyclists. Clinics (SãO Paulo, Brazil). 69: 867-70. PMID 25628001 DOI: 10.6061/Clinics/2014(12)13 |
0.322 |
|
| 2014 |
Rubin BK, Williams RW. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis. Respiration; International Review of Thoracic Diseases. 88: 177-84. PMID 25171580 DOI: 10.1159/000366000 |
0.356 |
|
| 2014 |
Rubin BK, Priftis KN, Schmidt HJ, Henke MO. Secretory hyperresponsiveness and pulmonary mucus hypersecretion. Chest. 146: 496-507. PMID 25091755 DOI: 10.1378/Chest.13-2609 |
0.389 |
|
| 2014 |
Rubin BK, Williams RW. Emerging aerosol drug delivery strategies: from bench to clinic. Advanced Drug Delivery Reviews. 75: 141-8. PMID 24993613 DOI: 10.1016/J.Addr.2014.06.008 |
0.331 |
|
| 2014 |
Haydour Q, Alahdab F, Farah M, Barrionuevo P, Vertigan AE, Newcombe PA, Pringsheim T, Chang AB, Rubin BK, McGarvey L, Weir KA, Altman KW, Feinstein A, Murad MH, Irwin RS. Management and diagnosis of psychogenic cough, habit cough, and tic cough: a systematic review. Chest. 146: 355-72. PMID 24833061 DOI: 10.1378/Chest.14-0795 |
0.326 |
|
| 2014 |
Nicola ML, Carvalho HB, Yoshida CT, Anjos FM, Nakao M, Santos Ude P, Cardozo KH, Carvalho VM, Pinto E, Farsky SH, Saldiva PH, Rubin BK, Nakagawa NK. Young "healthy" smokers have functional and inflammatory changes in the nasal and the lower airways. Chest. 145: 998-1005. PMID 24307008 DOI: 10.1378/Chest.13-1355 |
0.312 |
|
| 2014 |
Hoffer-Schaefer A, Rozycki HJ, Yopp MA, Rubin BK. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections. Respiratory Care. 59: 631-6. PMID 24003241 DOI: 10.4187/Respcare.02640 |
0.303 |
|
| 2013 |
Strickland SL, Rubin BK, Drescher GS, Haas CF, O'Malley CA, Volsko TA, Branson RD, Hess DR. AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respiratory Care. 58: 2187-93. PMID 24222709 DOI: 10.4187/Respcare.02925 |
0.354 |
|
| 2013 |
Rubin BK, Nakagawa NK. The authors respond to: CPAP in cystic fibrosis: is it time to surrender yet? Respiratory Care. 58: e117-8. PMID 23981593 DOI: 10.4187/Respcare.02714 |
0.347 |
|
| 2013 |
Rottier BL, Rubin BK. Asthma medication delivery: mists and myths. Paediatric Respiratory Reviews. 14: 112-8; quiz 118, 137. PMID 23522986 DOI: 10.1016/J.Prrv.2013.02.013 |
0.314 |
|
| 2013 |
Daviskas E, Rubin BK. Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Review of Respiratory Medicine. 7: 65-75. PMID 23362816 DOI: 10.1586/Ers.12.72 |
0.392 |
|
| 2012 |
Tanabe T, Rozycki HJ, Kanoh S, Rubin BK. Cardiac asthma: new insights into an old disease. Expert Review of Respiratory Medicine. 6: 705-14. PMID 23234454 DOI: 10.1586/Ers.12.67 |
0.353 |
|
| 2012 |
Rubin BK, Pohanka V. Beyond the guidelines: fatal and near-fatal asthma. Paediatric Respiratory Reviews. 13: 106-11. PMID 22475257 DOI: 10.1016/J.Prrv.2011.05.003 |
0.339 |
|
| 2012 |
Aquino ES, Shimura F, Santos AS, Goto DM, Coelho CC, de Fuccio MB, Saldiva PH, Lorenzi-Filho G, Rubin BK, Nakagawa NK. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis. Respiratory Care. 57: 1914-9. PMID 22417659 DOI: 10.4187/Respcare.01705 |
0.326 |
|
| 2012 |
Robinson P, Schechter MS, Sly PD, Winfield K, Smith J, Brennan S, Shinkai M, Henke MO, Rubin BK. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. Pediatric Pulmonology. 47: 551-7. PMID 22266895 DOI: 10.1002/Ppul.21613 |
0.376 |
|
| 2012 |
Register KB, Sukumar N, Palavecino EL, Rubin BK, Deora R. Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat. Zoonoses and Public Health. 59: 246-50. PMID 22212633 DOI: 10.1111/J.1863-2378.2011.01446.X |
0.309 |
|
| 2011 |
Seagrave J, Albrecht H, Park YS, Rubin B, Solomon G, Kim KC. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells. Experimental Lung Research. 37: 606-614. PMID 22044398 DOI: 10.3109/01902148.2011.623116 |
0.312 |
|
| 2011 |
Rubin BK. Pediatric aerosol therapy: new devices and new drugs. Respiratory Care. 56: 1411-21; discussion . PMID 21944688 DOI: 10.4187/respcare.01246 |
0.32 |
|
| 2011 |
John G, Chillappagari S, Rubin BK, Gruenert DC, Henke MO. Reduced surface toll-like receptor-4 expression and absent interferon-γ-inducible protein-10 induction in cystic fibrosis airway cells. Experimental Lung Research. 37: 319-26. PMID 21649525 DOI: 10.3109/01902148.2011.569968 |
0.314 |
|
| 2011 |
Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK. Serine proteases degrade airway mucins in cystic fibrosis. Infection and Immunity. 79: 3438-44. PMID 21646446 DOI: 10.1128/Iai.01252-10 |
0.381 |
|
| 2011 |
Rubin BK, Dhand R, Ruppel GL, Branson RD, Hess DR. Respiratory care year in review 2010: part 1. asthma, COPD, pulmonary function testing, ventilator-associated pneumonia. Respiratory Care. 56: 488-502. PMID 21496376 DOI: 10.4187/Respcare.01286 |
0.381 |
|
| 2010 |
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. American Journal of Respiratory and Critical Care Medicine. 182: 1292-304. PMID 20622029 DOI: 10.1164/Rccm.201002-0271Oc |
0.302 |
|
| 2010 |
Schmidt HJ, Bhandari V, Bhandari A, Davies J, Marshall BC, Praud JP, Zar HJ, Rubin BK. The future in paediatric respirology. Respirology (Carlton, Vic.). 15: 733-41. PMID 20409021 DOI: 10.1111/J.1440-1843.2010.01745.X |
0.4 |
|
| 2010 |
Rubin BK. Mucus and mucins. Otolaryngologic Clinics of North America. 43: 27-34, vii-viii. PMID 20172254 DOI: 10.1016/J.Otc.2009.11.002 |
0.391 |
|
| 2010 |
Rubin BK. The role of mucus in cough research. Lung. 188: S69-72. PMID 19936981 DOI: 10.1007/S00408-009-9198-7 |
0.377 |
|
| 2010 |
John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. American Journal of Respiratory Cell and Molecular Biology. 42: 424-31. PMID 19502387 DOI: 10.1165/Rcmb.2008-0408Oc |
0.32 |
|
| 2009 |
Bateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, Nadel JA, Pfeifer M, Racké K, Rabe KF, Rubin BK, Welte T, Wessler I. Alternative mechanisms for tiotropium. Pulmonary Pharmacology & Therapeutics. 22: 533-42. PMID 19635581 DOI: 10.1016/J.Pupt.2009.06.002 |
0.352 |
|
| 2009 |
Geller DE, Rubin BK. Respiratory care and cystic fibrosis. Respiratory Care. 54: 796-800. PMID 19467166 DOI: 10.4187/002013209790983241 |
0.377 |
|
| 2009 |
Rubin BK. Mucus, phlegm, and sputum in cystic fibrosis. Respiratory Care. 54: 726-32; discussion 7. PMID 19467160 DOI: 10.4187/002013209790983269 |
0.407 |
|
| 2009 |
Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 135: 505-12. PMID 19201713 DOI: 10.1378/Chest.08-0412 |
0.381 |
|
| 2009 |
Abanses JC, Arima S, Rubin BK. Vicks VapoRub induces mucin secretion, decreases ciliary beat frequency, and increases tracheal mucus transport in the ferret trachea. Chest. 135: 143-8. PMID 19136404 DOI: 10.1378/Chest.08-0095 |
0.36 |
|
| 2008 |
Robertson JM, Friedman EM, Rubin BK. Nasal and sinus disease in cystic fibrosis. Paediatric Respiratory Reviews. 9: 213-9. PMID 18694713 DOI: 10.1016/J.Prrv.2008.04.003 |
0.35 |
|
| 2008 |
Rubin BK. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21: 71-6. PMID 18518833 DOI: 10.1089/Jamp.2007.0652 |
0.387 |
|
| 2008 |
López-Boado YS, Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Current Opinion in Pharmacology. 8: 286-91. PMID 18339582 DOI: 10.1016/J.Coph.2008.01.010 |
0.396 |
|
| 2008 |
Kim JS, Rubin BK. Nasal and sinus involvement in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine. 14: 101-4. PMID 18303417 DOI: 10.1097/MCP.0b013e3282f4efc9 |
0.361 |
|
| 2008 |
Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacology & Therapeutics. 117: 393-405. PMID 18289694 DOI: 10.1016/J.Pharmthera.2007.11.001 |
0.34 |
|
| 2007 |
Kempainen RR, Williams CB, Hazelwood A, Rubin BK, Milla CE. Comparison of high-frequency chest wall oscillation with differing waveforms for airway clearance in cystic fibrosis. Chest. 132: 1227-32. PMID 17890465 DOI: 10.1378/Chest.07-1078 |
0.323 |
|
| 2007 |
Davies JC, Rubin BK. Emerging and unusual gram-negative infections in cystic fibrosis. Seminars in Respiratory and Critical Care Medicine. 28: 312-21. PMID 17562501 DOI: 10.1055/S-2007-981652 |
0.325 |
|
| 2007 |
Kim JS, Rubin BK. Nasal and sinus inflammation in chronic obstructive pulmonary disease. Copd. 4: 163-6. PMID 17530509 DOI: 10.1080/15412550701341228 |
0.401 |
|
| 2007 |
Rubin BK, Fink JB. Novel medications for asthma: a look at the future. Expert Opinion On Investigational Drugs. 16: 889-97. PMID 17501700 DOI: 10.1517/13543784.16.6.889 |
0.347 |
|
| 2007 |
Rubin BK. Mucus structure and properties in cystic fibrosis. Paediatric Respiratory Reviews. 8: 4-7. PMID 17419972 DOI: 10.1016/J.Prrv.2007.02.004 |
0.405 |
|
| 2007 |
Homnick DN, Marks JH, Rubin BK. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 20: 45-9. PMID 17388752 DOI: 10.1089/Jam.2006.0593 |
0.316 |
|
| 2007 |
Henke MO, John G, Germann M, Lindemann H, Rubin BK. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. American Journal of Respiratory and Critical Care Medicine. 175: 816-21. PMID 17255563 DOI: 10.1164/Rccm.200607-1011Oc |
0.386 |
|
| 2007 |
Rubin BK. CFTR is a modulator of airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology. 292: L381-2. PMID 17012368 DOI: 10.1152/Ajplung.00375.2006 |
0.359 |
|
| 2007 |
Okamoto K, Kim JS, Rubin BK. Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. American Journal of Physiology. Lung Cellular and Molecular Physiology. 292: L62-7. PMID 16951132 DOI: 10.1152/Ajplung.00181.2006 |
0.323 |
|
| 2006 |
Henke MO, Renner A, Rubin BK, Gyves JI, Lorenz E, Koo JS. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide. Experimental Lung Research. 32: 331-47. PMID 17090475 DOI: 10.1080/01902140600959580 |
0.321 |
|
| 2006 |
Rubin BK. Did Lady Windermere have cystic fibrosis? Chest. 130: 937-8. PMID 17035420 DOI: 10.1016/S0012-3692(15)51122-7 |
0.307 |
|
| 2006 |
Rubin BK. Other medications for aerosol delivery. Paediatric Respiratory Reviews. 7: S76-9. PMID 16798603 DOI: 10.1016/J.Prrv.2006.04.183 |
0.385 |
|
| 2006 |
Rubin BK. The pharmacologic approach to airway clearance: Mucoactive agents Paediatric Respiratory Reviews. 7: S215-S219. PMID 16798570 DOI: 10.1016/J.Prrv.2006.04.198 |
0.368 |
|
| 2006 |
Kim JS, Okamoto K, Rubin BK. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis Chest. 129: 1148-1154. PMID 16685004 DOI: 10.1378/Chest.129.5.1148 |
0.307 |
|
| 2006 |
Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK. Mucus properties in children with primary ciliary dyskinesia: Comparison with cystic fibrosis Chest. 129: 118-123. PMID 16424421 DOI: 10.1378/Chest.129.1.118 |
0.37 |
|
| 2006 |
Rubin BK, Kater AP, Goldstein AL. Thymosin β4 Sequesters Actin in Cystic Fibrosis Sputum and Decreases Sputum Cohesivity in Vitro Chest. 130: 1433-1440. DOI: 10.1016/S0012-3692(15)37320-7 |
0.301 |
|
| 2005 |
Henke MO, Shah SA, Rubin BK. The role of airway secretions in COPD--clinical applications. Copd. 2: 377-90. PMID 17147002 DOI: 10.1080/15412550500218148 |
0.389 |
|
| 2005 |
Shinkai M, Rubin BK. Macrolides and airway inflammation in children Paediatric Respiratory Reviews. 6: 227-235. PMID 16153572 DOI: 10.1016/J.Prrv.2005.06.005 |
0.369 |
|
| 2005 |
Daviskas E, Anderson SD, Gomes K, Briffa P, Cochrane B, Chan HK, Young IH, Rubin BK. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum Respirology. 10: 46-56. PMID 15691238 DOI: 10.1111/J.1440-1843.2005.00659.X |
0.325 |
|
| 2005 |
Barker PM, Gillie DJ, Schechter MS, Rubin BK. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. American Journal of Respiratory and Critical Care Medicine. 171: 868-71. PMID 15657462 DOI: 10.1164/Rccm.200311-1508Oc |
0.324 |
|
| 2005 |
Shinkai M, Chanf SP, Rubin BK. Immunomodulatory effects of macrolide antibiotics Clinical Pulmonary Medicine. 12: 341-348. DOI: 10.1097/01.Cpm.0000187294.53696.C0 |
0.306 |
|
| 2004 |
Rubin BK, Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest. 126: 1134-1137. PMID 15486374 DOI: 10.1378/Chest.126.4.1134 |
0.3 |
|
| 2004 |
Rubin BK. What does it mean when a patient says, "My asthma medication is not working?" Chest. 126: 972-981. PMID 15364781 DOI: 10.1378/Chest.126.3.972 |
0.303 |
|
| 2004 |
Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions American Journal of Respiratory Cell and Molecular Biology. 31: 86-91. PMID 14988081 DOI: 10.1165/Rcmb.2003-0345Oc |
0.376 |
|
| 2004 |
Fuloria M, Wu Y, Brandt ML, Rubin BK. Effect of meconium on the surface properties of perflubron. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 5: 167-71. PMID 14987348 DOI: 10.1097/01.Pcc.0000113262.00950.82 |
0.306 |
|
| 2004 |
Rubin BK, Henke MO. Immunomodulatory Activity and Effectiveness of Macrolides in Chronic Airway Disease Chest. 125: 70S-78S. PMID 14872003 DOI: 10.1378/Chest.125.2_Suppl.70S |
0.411 |
|
| 2004 |
Gozal D, Rubin BK. Introduction to CIPP V: A paediatric forum for respiratory disease Paediatric Respiratory Reviews. 5: S1. DOI: 10.1016/S1526-0542(04)90000-0 |
0.337 |
|
| 2003 |
Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children Chest. 124: 790-794. PMID 12969999 DOI: 10.1378/Chest.124.3.790 |
0.324 |
|
| 2003 |
Rubin BK, Fink JB. The delivery of inhaled medication to the young child Pediatric Clinics of North America. 50: 717-731. PMID 12877243 DOI: 10.1016/S0031-3955(03)00049-X |
0.332 |
|
| 2003 |
Rubin BK. A scientific koan: What is the cause of cystic fibrosis? Chest. 123: 1792-1793. PMID 12796151 DOI: 10.1378/Chest.123.6.1792 |
0.311 |
|
| 2003 |
Rubin BK. Cystic fibrosis: Bench to bedside 2003 Canadian Respiratory Journal. 10: 161-164. PMID 12712228 DOI: 10.1155/2003/797054 |
0.389 |
|
| 2003 |
Bush A, Rubin BK. Macrolides as Biological Response Modifiers in Cystic Fibrosis and Bronchiectasis Seminars in Respiratory and Critical Care Medicine. 24: 737-747. DOI: 10.1055/S-2004-815669 |
0.382 |
|
| 2003 |
Rubin BK. Overview of Cystic Fibrosis' and Non-CF Bronchiectasis Seminars in Respiratory and Critical Care Medicine. 24: 619-627. DOI: 10.1055/S-2004-815658 |
0.302 |
|
| 2002 |
King M, Rubin BK. Pharmacological approaches to discovery and development of new mucolytic agents Advanced Drug Delivery Reviews. 54: 1475-1490. PMID 12458156 DOI: 10.1016/S0169-409X(02)00156-4 |
0.361 |
|
| 2001 |
Rubin BK, Tomkiewicz R, Fahy JV, Green FHY. Histopathology of fatal asthma: Drowning in mucus Pediatric Pulmonology. 32: 88-89. PMID 11886162 DOI: 10.1002/Ppul.1950322336 |
0.305 |
|
| 2001 |
Padda GS, Kishioka C, Rubin BK. Propofol and methohexital have no significant effect on mucus secretion or clearance in the anesthetized dog Critical Care Medicine. 29: 1045-1048. PMID 11378620 DOI: 10.1097/00003246-200105000-00035 |
0.356 |
|
| 2001 |
Kishioka C, Okamoto K, Kim J, Rubin BK. Regulation of secretion from mucous and serous cells in the excised ferret trachea Respiration Physiology. 126: 163-171. PMID 11348643 DOI: 10.1016/S0034-5687(01)00214-6 |
0.323 |
|
| 1999 |
Van Der Schans CP, Postma DS, Koëter GH, Rubin BK. Physiotherapy and bronchial mucus transport European Respiratory Journal. 13: 1477-1486. PMID 10445628 DOI: 10.1183/09031936.99.13614879 |
0.337 |
|
| 1999 |
Kishioka C, Okamoto K, Hassett DJ, De Mello D, Rubin BK. Pseudomonas aeruginosa alginate is a potent secretagogue in the isolated ferret trachea Pediatric Pulmonology. 27: 174-179. PMID 10213255 DOI: 10.1002/(Sici)1099-0496(199903)27:3<174::Aid-Ppul4>3.0.Co;2-A |
0.358 |
|
| 1999 |
Rubin BK. Emerging therapies for cystic fibrosis lung disease Chest. 115: 1120-1126. PMID 10208218 DOI: 10.1378/Chest.115.4.1120 |
0.332 |
|
| 1999 |
Macek V, Dakhama A, Hogg JC, Green FH, Rubin BK, Hegele RG. PCR detection of viral nucleic acid in fatal asthma: is the lower respiratory tract a reservoir for common viruses? Canadian Respiratory Journal. 6: 37-43. PMID 10202219 DOI: 10.1155/1999/938049 |
0.324 |
|
| 1999 |
Kishioka C, Dorighi MP, Rubin BK. Perfluorooctyl bromide (Perflubron) stimulates mucin secretion in the ferret trachea Chest. 115: 823-828. PMID 10084498 DOI: 10.1378/Chest.115.3.823 |
0.323 |
|
| 1999 |
Rubin BK. Manipulation of Volume vs Osmolality in Cystic Fibrosis Lung Disease Chest. 116: 1495. DOI: 10.1016/S0012-3692(15)51643-7 |
0.336 |
|
| 1998 |
Grasemann H, Ioannidis I, Tomkiewicz RP, De Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease Archives of Disease in Childhood. 78: 49-53. PMID 9534676 DOI: 10.1136/Adc.78.1.49 |
0.364 |
|
| 1997 |
Rubin BK, Druce H, Ramirez OE, Palmer R. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. American Journal of Respiratory and Critical Care Medicine. 155: 2018-23. PMID 9196110 DOI: 10.1164/Ajrccm.155.6.9196110 |
0.357 |
|
| 1997 |
Rubin BK, Kumar V. Chronic Lung Disease in Canadian Aboriginal Children Is Not Caused by Abnormal Cilia Canadian Respiratory Journal. 4: 211-214. DOI: 10.1155/1997/319024 |
0.338 |
|
| 1996 |
Rubin BK, Tomkiewicz RP, Patrinos ME, Easa D. The surface and transport properties of meconium and reconstituted meconium solutions. Pediatric Research. 40: 834-838. PMID 8947959 DOI: 10.1203/00006450-199612000-00010 |
0.327 |
|
| 1996 |
Rubin BK, Ramirez O, Ohar JA. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest. 109: 348-52. PMID 8620704 DOI: 10.1378/Chest.109.2.348 |
0.355 |
|
| 1994 |
Sanctis GD, Tomkiewicz R, Rubin B, Schurch S, King M. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog European Respiratory Journal. 7: 1616-1621. PMID 7995390 DOI: 10.1183/09031936.94.07091616 |
0.331 |
|
| 1992 |
Rubin BK, Ramirez O, King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest. 101: 1080-5. PMID 1555424 DOI: 10.1378/Chest.101.4.1080 |
0.376 |
|
| 1991 |
Rubin BK, Macleod PM, Sturgess J, King M. Recurrent respiratory infections in a child with fucosidosis: is the mucus too thin for effective transport? Pediatric Pulmonology. 10: 304-309. PMID 1896242 DOI: 10.1002/Ppul.1950100415 |
0.331 |
|
| 1991 |
App EM, De Sanctis GT, Green FH, Hulbert WC, Rubin BK, Remmers JE, King M. Neonatal capsaicin treatment alters basal pulmonary mechanics and response to methacholine in F344 rats. Journal of Applied Physiology (Bethesda, Md. : 1985). 70: 2087-94. PMID 1713907 DOI: 10.1152/Jappl.1991.70.5.2087 |
0.3 |
|
| 1990 |
Rubin BK, Ramirez O, Zayas JG, Finegan B, King M. Collection and analysis of respiratory mucus from subjects without lung disease. The American Review of Respiratory Disease. 141: 1040-3. PMID 2327638 DOI: 10.1164/Ajrccm/141.4_Pt_1.1040 |
0.319 |
|
| Show low-probability matches. |
